Showing 1 posts of 1 posts found.


Regeneron halts Phase 1 study into ultra-rare disease due to patient deaths

November 3, 2020
Manufacturing and Production, Research and Development Regeneron, clinical trials, garetosmab, pharma

Regeneron has slammed the brakes on its Phase 1 trial of garetosmab in the treatment of the ultra-rare condition fibrodysplasia …

Latest content